ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataShowing 20 of 12554 recruiting trials
RecruitingNCT05612022 ↗
Acoustic Analysis of VA Sounds
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
👨⚕️ Xiangmei Chen, PhD, Chinese PLA General Hospital, Beijing, China📍 1 site📅 Started May 2023View details ↗
Study of LYL314 in Aggressive Large B-Cell Lymphoma
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
👨⚕️ Evan Osmundson, MD, PhD, Vanderbilt University/Ingram Cancer Center📍 1 site📅 Started May 2023View details ↗
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants
G7 Freedom Constrained Vivacit-E Liners
taVNS for Persistent Symptoms From Lyme Disease
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
RecruitingNCT06625203 ↗
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors
👨⚕️ Lingying Wu, Professor, Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 11 sites📅 Started May 2023View details ↗
Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma
OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
RecruitingNCT05894369 ↗
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
👨⚕️ Jonathan Brammer, MD, Ohio State University Comprehensive Cancer Center📍 3 sites📅 Started May 2023View details ↗
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →